https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15375 Wed 11 Apr 2018 15:55:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21150 Wed 11 Apr 2018 12:44:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14595 Wed 04 Sep 2019 11:33:48 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48005 Tue 14 Feb 2023 17:18:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:407 Thu 25 Jul 2013 09:09:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48967 Thu 20 Apr 2023 10:09:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46604 400 g and/or >20-weeks' gestation, to women diagnosed with breast cancer in the first or second trimesters. Eighteen babies were exposed in utero to chemotherapy. Chemotherapy commenced at a median of 20 weeks gestation, for a mean duration of 10 weeks. Twelve exposed infants were born preterm with 11 by induced labour or pre-labour caesarean section. There were no perinatal deaths or congenital malformations. Our findings show that breast cancer diagnosed during mid-pregnancy is often treated with chemotherapy. Other than induced preterm births, there were no serious adverse perinatal outcomes.]]> Mon 28 Nov 2022 08:30:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53260 Mon 20 Nov 2023 12:13:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48946 1 (AOR 3.94) was an independent predictor of adverse perinatal events. In women with isolated MR, use of cardiac medications (AOR 7.03) and use of anticoagulants (AOR 6.05) were independently associated with adverse cardiac outcomes. Conclusions: Careful monitoring and specialist care for women with RHD in pregnancy is required, particularly for women with severe MS, those on cardiac medication, and those on anticoagulation, as these are associated with increased risk of adverse maternal cardiac outcomes. In the context of pregnancy, contraception and preconception planning are important for young women diagnosed with RHD.]]> Mon 17 Apr 2023 16:42:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44174 Mon 10 Oct 2022 10:13:30 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47321 Fri 13 Jan 2023 11:06:47 AEDT ]]>